About BPC-157
What is BPC-157?
BPC-157 (Body Protective Compound 157) is a synthetic pentadecapeptide derived from a sequence identified in human gastric juice. It is one of the most widely cited research peptides in the soft-tissue and gastric-repair literature.
Preclinical work has explored BPC-157 across models of tendon, ligament, and gastrointestinal injury, with mechanisms broadly tied to angiogenesis, nitric-oxide signaling, and growth-factor expression.
How it's studied — mechanism
BPC-157's reported activity in pre-clinical literature includes:
- Modulation of angiogenesis and capillary network formation
- Up-regulation of the nitric-oxide (NO) pathway and VEGF expression
- Enhanced fibroblast migration and growth-factor receptor expression
- Cytoprotective effects in gastric and intestinal mucosa models
Amino acid sequence
Primary structure
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-ValPublished research
The following primary sources are provided to support qualified-researcher review. Inclusion is for reference only and does not constitute medical advice or therapeutic claim.
Primary literature
Research use only
BPC-157 is sold strictly for in-vitro research by qualified researchers and is not approved by the FDA for any therapeutic indication. It is not intended to diagnose, treat, cure, or prevent any disease, and is not intended for human or veterinary consumption. All statements on this page describe published research literature and do not constitute medical claims. By purchasing you agree to use BPC-157 only in accordance with applicable federal, state, and local law.